Stock Comparison

MDGL vs VRTX

Madrigal Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

MDGL

Madrigal Pharmaceuticals Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$11.60B

$123.94B

P/E (TTM)

—

28.5

Forward P/E

656.4

25.7

Price/Sales

9.0

9.9

Price/Book

22.1

6.1

EV/EBITDA

-8.2

23.2

Dividend Yield

—

Profitability

Net Margin

-27.32%

35.40%

Operating Margin

-27.68%

38.97%

Return on Equity

-53.30%

23.50%

Return on Assets

-17.80%

11.90%

Growth (YoY)

Revenue Growth

71.20%

12.50%

Earnings Growth

0.00%

8.00%

Price & Risk

Beta

-1.0

0.3

52-Week High

$602.83

$529.65

52-Week Low

$369.84

$376.62

Analyst Target

$678.06

$559.28

Compare MDGL and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.